🔥 CYBER MONDAY SALE ENDS TONIGHT: Save 30% or more on all Examine products Save now »

Studies related to Schizophrenia and Cannabis

Cannabinoids For The Treatment Of Mental Disorders And Symptoms Of Mental Disorders: A Systematic Review And Meta-analysis

Effect Increase
Values A single study found that pharmaceutical THC:CBD had no effect on positive symptoms (such as hallucinations), but worsened negative symptoms (such as reduced emotional expression, motivation, and spontaneous speech).
Trial Design Meta analysis
Trial Length n/a
Number of Subjects 2067
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Notes for this study:
This meta-analysis included 40 randomized controlled trials related to the use of cannabis, THC, and CBD in Depression, Anxiety, ADHD, Tic/Tourette syndrome, PTSD, and Psychosis.